Simon Meadowcroft News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simon Meadowcroft. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simon Meadowcroft Today - Breaking & Trending Today

Takeda UK Ltd: NICE recommends LIVTENCITY? (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) refractory (with or without resistance) to prior therapies

Published: December 8, 2022

Takeda UK Ltd. is pleased to announce that NICE has recommended the use of LIVTENCITY? (maribavir) as a twice daily oral treatment for adult patients with post-transplant cytomegalovirus (CMV)

Source: finanznachrichten.de

Related Topics:

United KingdomCity OfRachel MillerEl ChaerAnthony NolanPeter WheatleyMark HarberSimon MeadowcroftMaribavir SmDrug AdministrationPrnewswire Takeda United Kingdom LtdBritish Society Of BloodRegulatory AgencyTakeda Pharmaceutical CompanyNational Institute For HealthTakeda Pharmaceutical Company LimitedTakeda United Kingdom LtdTakeda United KingdomTransplanted OrganNational InstituteCare ExcellenceFinal Appraisal DeterminationMarketing AuthorisationLead NurseConsultant Nephrologist